The trading debut follows Flowr’s recent raise of 36 million Canadian dollars ($27.7 million) and reverse takeover of a shell company previously listed on the exchange.
The company has a license from Health Canada and agreements in place to sell cannabis in three provinces for adult recreational use when that market launches Oct. 17.
Founded by Tom Flow, a co-founder of MedReleaf, the company is in the midst of building out an 85,000-square-foot cultivation facility in Kelowna, British Columbia.
The facility is about 20% operational, with the remainder expected to go online in 2019, according to the company.
In March, Flowr entered into an exclusive research and development agreement with Hawthorne Gardening Co., a subsidiary of Columbus, Ohio-based Scotts Miracle-Gro.
Under that agreement, Hawthorne will cover the costs to build a 50,000-square-foot facility to house researchers from both firms as well as indoor greenhouses, genetics breeding areas and training areas.
That facility is expected to open next year.